Why the study?
Does antiplatelet therapy reduce the severity of subsequent stroke in patients with prior stroke or TIA?
Population
6,602 patients with stroke or TIA as the qualifying event. The analysis focused on 701 patients with new…
Comparison
Antiplatelet therapy: acetylsalicylic acid 2 x… vs Placebo
Design
RCT
Follow-up
2 years
Authors
Loading...
Antiplatelet therapy does not lessen recurrent stroke severity; extends evidence that benefit is confined to delaying events.
Does antiplatelet therapy reduce the severity of subsequent stroke in patients with prior stroke or TIA?
Antiplatelet therapy delays the occurrence of recurrent stroke but does not reduce the clinical severity of the recurrent event when it occurs.
Sivenius et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: